Javascript must be enabled to continue!
Supplementary Figure S2 from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
View through CrossRef
<p>Figure S2: Disruption of BSG, by zinc finger nucleases, reduces lactic acid transport, inhibits glycolysis and sensitizes U87 cells to the MCT1 inhibitor and phenformin.</p>
American Association for Cancer Research (AACR)
Title: Supplementary Figure S2 from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Description:
<p>Figure S2: Disruption of BSG, by zinc finger nucleases, reduces lactic acid transport, inhibits glycolysis and sensitizes U87 cells to the MCT1 inhibitor and phenformin.
</p>.
Related Results
Data from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Data from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
<div>Abstract<p>Rapidly growing glycolytic tumors require energy and intracellular pH (pHi) homeostasis through the activity of two major monocarboxylate transporters, ...
Data from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Data from Genetic Disruption of Lactate/H<sup>+</sup> Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
<div>Abstract<p>Rapidly growing glycolytic tumors require energy and intracellular pH (pHi) homeostasis through the activity of two major monocarboxylate transporters, ...
Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
Cholangiocarcinoma (CCA), an aggressive cancer of bile ducts, is a well-known chronic inflammation-related disease. The major impediment in CCA treatment is limited treatment optio...
Identification of ADAM12 as a Novel Basigin Sheddase
Identification of ADAM12 as a Novel Basigin Sheddase
The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and th...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity
L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity
Abstract
Since O. Warburg first proposed aerobic glycolysis to be the main bioenergetic pathway activated in cancer cells, there has been near silence on the differe...
CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells
CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells
Although previous evidence indicates close involvement of CD147 in the pathogenesis of liver fibrosis, the underlying molecular mechanisms and its therapeutic value remain largely ...
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
AbstractChimeric antigen receptor (CAR) T cell therapy has shown promising results in hematologic malignancies, but its effectiveness in solid cancers remains challenging. Macropha...

